Clinical Trial

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

Study acronym: FINDER-AF
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-18.
Trial Details
NCT Number NCT06892938
Lead Sponsor Everbeat
Conditions Atrial Fibrillation (AF), Arrhythmias Cardiac, Tachycardia, Palpitations, Bradycardia
Enrollment 232 participants
Start Date 2024-09-17
Primary Completion 2025-03-12 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-27